Clinical trials sponsored by Guangdong Association of Clinical Trials

Phase breakdown

Conditions studied

Recruiting trials led by Guangdong Association of Clinical Trials

• Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study
  NCT07696832 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  NCT07198841 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• RGL-270 + ICI in Advanced NSCLC
  NCT07652125 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Guangdong Association of Clinical Trials recruiting for?

Guangdong Association of Clinical Trials is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.